Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. This appears to be a backend/versioning update and does not change study content.SummaryDifference0.1%

- Check24 days agoChange Detected- Removed a site-wide notice about a lapse in government funding and NIH operating status. The study record details (title, conditions, interventions, outcomes) remain unchanged.SummaryDifference0.4%

- Check38 days agoChange DetectedNo additions or deletions were detected between the two screenshots, and the Study Details page content and layout appear unchanged.SummaryDifference0.5%

- Check67 days agoChange DetectedMajor update: version bumped to v3.2.0 with a prominent notice about funding-related access limits and where to check current operating status; previously listed v3.1.0 has been removed.SummaryDifference2%

- Check74 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.